Cancer Diagnostics Market – Global Trends and Forecast to 2024


@databridgemarketresearch


Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

Global Cancer Diagnostics Market, By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024


Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.


Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market


Key factors propelling growth of this market are technological advancements in the diagnostics imaging systems, growing number of cancer patients globally, rapidly aging population, and huge government support for research in cancer diagnostics. However, factors such as the dearth of skilled professionals and high capital investments for imaging systems are restraining the growth of the market.


The market is segmented on the basis of technology and application, and geography.


The global cancer diagnostics market, by technology, is categorized into two main segments—platform based and instrument-based. Platform-based segment is further segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), DNA Microarrays, Flow Cytometry and other technologies. Instrument-based segment is further segmented into Imaging (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), mammography, and ultrasound), and Biopsy.


The global cancer diagnostics market, by application into lung cancer, breast cancer, colorectal cancer, melanoma and other forms of cancer. Breast cancer diagnosis is expected to hold the largest share of this market in 2015, due to very high prevalence in North America also due to very high cost of mammography instruments.


Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.


Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market


Some of the major Companies operating in this market are:


·         Abbott Laboratories, Inc.

·         Thermo Fisher Scientific, Inc.

·         Illumina, Inc.

·         Becton

·         Dickinson and Company

·         GE Healthcare

·         QIAGEN N.V.

·         Agilent Technologies, Inc.

·         Roche Diagnostics

·         Siemens Healthcare

·         Philips Healthcare

·         C.R. Bard, Inc.

·         Hologic, Inc.


Table of Content:


1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY

       6.1. OVERVIEW

       6.2. PLATFORM BASED, BY PRODUCT TYPE

       6.3. INSTRUMENT BASED, BY PRODUCT TYPE

7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION

9. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY

       9.1. COUNTRYWISE GLOBAL CANCER DIAGNOSTICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

                9.1.1. NORTH AMERICA

                 9.1.2. EUROPE

                 9.1.3. ASIA-PACIFIC (APAC)

                 9.1.4. LATIN AMERICA

                           9.1.4.1. BRAZIL

                           9.1.4.2. REST OF LATIN AMERICA

                 9.1.5. MIDDLE EAST AND AFRICA

                           9.1.5.1. SOUTH AFRICA

                           9.1.5.2. REST OF MIDDLE EAST AND AFRICA

       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. GLOBAL CANCER DIAGNOSTICS MARKET: COMPETITIVE LANDSCAPE

       10.1. GLOBAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.3. EUROPE CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.4. APAC CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.5. MEA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.6. SOUTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.7. MERGERS & ACQUISITIONS

       10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

       10.9. EXPANSIONS

       10.10. REGULATORY CHANGES

       10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY PROFILES

       11.1. ABBOTT

                 11.1.1. COMPANY OVERVIEW

                 11.1.2. FINANCIAL ANALYSIS

                 11.1.3. PRODUCT MATRIX

                 11.1.4. RECENT DEVELOPMENTS

                 11.1.5. DATABRIDGE ANALYSIS

       11.2. THERMO FISHER SCIENTIFIC

                 11.2.1. COMPANY OVERVIEW

                 11.2.2. FINANCIAL ANALYSIS

                 11.2.3. PRODUCT MATRIX

                 11.2.4. RECENT DEVELOPMENTS

                 11.2.5. DATABRIDGE ANALYSIS

       11.3. ILLUMINA, INC.

                 11.3.1. COMPANY OVERVIEW

                 11.3.2. FINANCIAL ANALYSIS

                 11.3.3. PRODUCT MATRIX

                 11.3.4. RECENT DEVELOPMENTS

                 11.3.5. DATABRIDGE ANALYSIS

       11.4. GE HEALTHCARE

                 11.4.1. COMPANY OVERVIEW

                 11.4.2. FINANCIAL ANALYSIS

                 11.4.4. PRODUCT MATRIX

                 11.4.4. RECENT DEVELOPMENTS

                 11.4.5. DATABRIDGE ANALYSIS

       11.5. SIEMENS HEALTHCARE GMBH

                 11.5.1. COMPANY OVERVIEW

                 11.5.2. FINANCIAL ANALYSIS

                 11.5.3. PRODUCT MATRIX

                 11.5.4. RECENT DEVELOPMENTS

                 11.5.5. DATABRIDGE ANALYSIS

       11.6. QIAGEN

                 11.6.1. COMPANY OVERVIEW

                 11.6.2. FINANCIAL ANALYSIS

                 11.6.3. PRODUCT MATRIX

                 11.6.4. RECENT DEVELOPMENTS

                 11.6.5. DATABRIDGE ANALYSIS

       11.7. AGILENT TECHNOLOGIES

                 11.7.1. COMPANY OVERVIEW

                 11.7.2. FINANCIAL ANALYSIS

                 11.7.3. PRODUCT MATRIX

                 11.7.4. RECENT DEVELOPMENTS

                 11.7.5. DATABRIDGE ANALYSIS

       11.8. ROCHE DIAGNOSTICS

                 11.8.1. COMPANY OVERVIEW

                 11.8.2. FINANCIAL ANALYSIS

                 11.8.3. PRODUCT MATRIX

                 11.8.4. RECENT DEVELOPMENTS

                11.8.5. DATABRIDGE ANALYSIS

       11.9. KONINKLIJKE PHILIPS N.V.

                 11.9.1. COMPANY OVERVIEW

                 11.9.2. FINANCIAL ANALYSIS

                 11.9.3. PRODUCT MATRIX

                 11.9.4. RECENT DEVELOPMENTS

                 11.9.5. DATABRIDGE ANALYSIS

       11.10. BECTON, DICKINSON & COMPANY

                 11.10.1. COMPANY OVERVIEW

                 11.10.2. FINANCIAL ANALYSIS

                 11.10.3. PRODUCT MATRIX

                 11.10.4. RECENT DEVELOPMENTS

                 11.10.5. DATABRIDGE ANALYSIS

       11.11. C.R. BARD, INC.

                 11.11.1. COMPANY OVERVIEW

                 11.11.2. FINANCIAL ANALYSIS

                 11.11.3. PRODUCT MATRIX

                 11.11.4. RECENT DEVELOPMENTS

                 11.11.5. DATABRIDGE ANALYSIS

       11.12. HOLOGIC, INC.

                 11.12.1. COMPANY OVERVIEW

                 11.12.2. FINANCIAL ANALYSIS

                 11.12.3. PRODUCT MATRIX

                 11.12.4. RECENT DEVELOPMENTS

                 11.12.5. DATABRIDGE ANALYSIS

 

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/in-vitro-diagnostics/global-cancer-diagnostics-market/


Related Report


North America Cancer Diagnostics Market – Industry Trends and Forecast to 2024


North America Cancer Diagnostics Market By Product Type, By End User, By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024


Report Access: http://databridgemarketresearch.com/reports/in-vitro-diagnostics/north-america-cancer-diagnostics-market/


About Data Bridge Market Research:


Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/  

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

 

Economy News